spirogermanium has been researched along with Cancer of Colon in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Bodey, GP; Legha, SS | 1 |
| Castronovo, FP; DeLuca, SA; Rhea, JT | 1 |
| Bellamy, AS; Hill, BT; Jenkins, LY; Whatley, SA; Whelan, RD | 1 |
| Badger, AM; Dorman, J; Hillegass, L; Johnson, RK; Martellucci, S; Mirabelli, CK; Picker, D; Schwartz, D; Sung, CM; Sung, CP | 1 |
| Asbury, RF; Haller, DG; Kramar, A; Pandya, KJ | 1 |
| Ajani, JA; Boman, BM; Faintuch, JS; Krakoff, IH; Levin, B; McClure, RK | 1 |
6 other study(ies) available for spirogermanium and Cancer of Colon
| Article | Year |
|---|---|
Phase I study of spirogermanium given daily.
Topics: Adult; Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Lymphoma; Male; Middle Aged; Nausea; Nervous System Diseases; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1983 |
The effects of chemotherapy on bony metastases as measured by quantitative skeletal imaging.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Colonic Neoplasms; Diphosphonates; Fluorouracil; Germanium; Humans; Male; Middle Aged; Organometallic Compounds; Radionuclide Imaging; Spiro Compounds; Technetium; Technetium Compounds; Time Factors | 1983 |
Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Survival; Cells, Cultured; Colonic Neoplasms; Cricetinae; Female; Germanium; Humans; Mesocricetus; Neuroblastoma; Neurons; Organometallic Compounds; Ovary; Rats; Spiro Compounds | 1982 |
Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
Topics: Animals; Antineoplastic Agents; Carcinoma; Colonic Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Leukemia P388; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred Strains; Organometallic Compounds; Plasmacytoma; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 1989 |
A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study.
Topics: Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Organometallic Compounds; Rectal Neoplasms; Spiro Compounds | 1988 |
Phase II study of spirogermanium in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Organometallic Compounds; Rectal Neoplasms; Spiro Compounds | 1986 |